Results 191 to 200 of about 3,283,768 (383)

CD8+ T‐cell memory in tumor immunology and immunotherapy [PDF]

open access: green, 2006
Christopher A. Klebanoff   +2 more
openalex   +1 more source

Robust Systemic and Mucosal Immune Responses to Coxsackievirus B3 Elicited by Spider Silk Protein Based Nanovaccines via Subcutaneous Immunization

open access: yesAdvanced Functional Materials, EarlyView.
Spider minor ampullate silk protein (MiSp) and retinoic acid (RA) based nanovaccine are capable of eliciting both mucosal and systemic immune responses following subcutaneous administration and demonstrate significant protective effects against CVB3 infection in mice.
Xingmei Qi   +4 more
wiley   +1 more source

In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications

open access: yesBMC Cancer
Background CCR8-expressing regulatory T cells (Tregs) are selectively localized within tumors and have gained attention as potent suppressors of anti-tumor immunity.
Yoshinori Hayashi   +12 more
doaj   +1 more source

A Two-Stage Approach for Segmenting Spatial Point Patterns Applied to Multiplex Imaging [PDF]

open access: yesarXiv
Recent advances in multiplex imaging have enabled researchers to locate different types of cells within a tissue sample. This is especially relevant for tumor immunology, as clinical regimes corresponding to different stages of disease or responses to treatment may manifest as different spatial arrangements of tumor and immune cells.
arxiv  

The complex role of B7 molecules in tumor immunology [PDF]

open access: green, 2008
Barbara Seliger   +3 more
openalex   +1 more source

TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer. [PDF]

open access: yes, 2019
Tumor antigen-driven selection may expand T cells having T cell receptors (TCRs) of shared antigen specificity but different amino acid or nucleotide sequence in a process known as TCR convergence. Substitution sequencing errors introduced by TCRβ (TCRB)
Conroy, Jeffrey   +7 more
core  

Electric Pulse Regulated MXene Based Nanozymes for Integrative Bioelectricity Immuno‐Cancer Therapy

open access: yesAdvanced Functional Materials, EarlyView.
MXenzyme‐mediated bioelectricity cancer therapy (MXenzyme‐BECT) enhances cancer cell death through irreversible depolarization, ion channel disruption, ROS generation, and immunogenic cell death. Computational simulations reveal the electrical mechanisms by which MXenzyme acts on single cells and support to predict treatment parameters. Next‐generation
Sanghee Lee   +6 more
wiley   +1 more source

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer

open access: yesOncoImmunology, 2018
The immune system plays an essential role in eradicating cancer in concert with various treatment modalities. In the absence of autologous tumor material, no standardized method exists to assess T cell responses against the many antigens that may serve ...
Rieneke van de Ven   +10 more
doaj   +1 more source

Tumor immunology top 10 list [PDF]

open access: bronze, 2008
Olivera J. Finn
openalex   +1 more source

Dendritic Cells in Cancer Immunology and Immunotherapy

open access: yesCancers
Simple Summary Although immune check point inhibitors have been established as a new paradigm in cancer treatment, they have shown no clinical benefit in immune excluded or dessert tumors.
L. Hato   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy